APA (7th ed.) Citation

K, A., T, K., S, Y., K, O., K, A., H, S., . . . Imai, Y. (2010). Impact of functional ABCG2 polymorphisms on the adverse effects of gefitinib in Japanese patients with non-small-cell lung cancer. Cancer Chemotherapy & Pharmacology, 66(4), 691. https://doi.org/10.1007/s00280-009-1211-6

Chicago Style (17th ed.) Citation

K, Akasaka, et al. "Impact of Functional ABCG2 Polymorphisms on the Adverse Effects of Gefitinib in Japanese Patients with Non-small-cell Lung Cancer." Cancer Chemotherapy & Pharmacology 66, no. 4 (2010): 691. https://doi.org/10.1007/s00280-009-1211-6.

MLA (9th ed.) Citation

K, Akasaka, et al. "Impact of Functional ABCG2 Polymorphisms on the Adverse Effects of Gefitinib in Japanese Patients with Non-small-cell Lung Cancer." Cancer Chemotherapy & Pharmacology, vol. 66, no. 4, 2010, p. 691, https://doi.org/10.1007/s00280-009-1211-6.